Efficacy and Methodology of Remote Heart Rate Variability Biofeedback Interventions for Mental Health: A Systematic Review and Meta-Analysis.

Appl Psychophysiol BiofeedbackNov 27, 2025 (epub)
Clinical ResearchPsychiatryOpen access

Sophia Vann-Adibe, Harry Kam Hung Tsui, Hui Quan Zhou et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis assessed remote heart rate variability biofeedback (HRV-B) for mental health symptoms and HRV across 18 studies involving 1,352 participants from different populations. Compared with control conditions, HRV-B was associated with a medium effect on depressive symptoms (g = -0.41, p = 0.026) and HRV (g = 0.443, p = 0.002); both findings remained significant in sensitivity analyses. The effect on stress was not significant. Meta-regression suggested that study and protocol characteristics moderated outcomes, although the abstract does not establish these factors as causal.

Key findings

  • HRV-B improved depressive symptoms versus control conditions (g = -0.41, p = 0.026; k = 10).
  • HRV-B increased HRV versus control conditions (g = 0.443, p = 0.002; k = 10).
  • The effect on stress was not significant (p = 0.152; k = 8).
  • Meta-regressions identified study and protocol characteristics as moderators of effects on HRV, stress, and anxiety.

Why it matters

The pooled findings suggest remote HRV-B may offer benefits for depressive symptoms and autonomic function across varied populations. The lack of a significant stress effect and the reported moderation by study and protocol characteristics indicate that outcomes may not be uniform. These results help frame the potential and uncertainty of remote delivery without establishing which protocol features should be adopted.

What to keep in mind

The review combined studies from different populations and protocols, and heterogeneity was substantial for depression (I² = 72.623%) and moderate for HRV (I² = 56.81%).

Source

Published in Appl Psychophysiol Biofeedback. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.